aTYR Pharma Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
aTYR Pharma Inc
CIK #0001339970
EDGAR Form CIK 2011 - 2026
10-K [0001339970]
10-Q [0001339970]
3 [0001339970]
4 [0001339970]
8-K [0001339970]
D [0001339970]
SC 13D [0001339970]
SC 13G [0001339970]
Form 13D/13G Filer Form 13D/13G Subject Filed
Vanguard Group Inc ATYR Pharma Inc [2025-07-29]
BlackRock Inc ATYR Pharma Inc [2025-07-17]
Point72 Asset Management LP ATYR Pharma Inc [2024-10-15]
Logos Global Management LP ATYR Pharma Inc [2024-01-02]
Lytton Laurence W ATYR Pharma Inc [2023-02-22]
Venrock Healthcare Capital Partners II LP ATYR Pharma Inc [2021-09-27]
Ikarian Capital LLC ATYR Pharma Inc [2021-09-17]
Tang Capital Partners LP ATYR Pharma Inc [2021-09-17]
Aspire Capital Fund LLC ATYR Pharma Inc [2021-02-17]
Alyeska Investment Group LP ATYR Pharma Inc [2021-02-16]
View All
Form 3/4/5 Subject 2011 - 2026
Schimmel Paul
aTYR Pharma Inc
Coughlin Timothy
Zaknoen Sara
Gross Jane A
Lucas Svetlana
Benevich Eric
Broadfoot Jill Marie
Denyes Nancy
Shukla Sanjay
Clarke John K
Hatfield Jeffrey S
Blair James C
Mendlein John
Amanullah Ashraf
Nashat Amir
EcoR1 Capital Fund Qualified LP
Blackburn Stan
King David John
Blake John T
Goldberg Mark Alan
Akkaraju Srinivas
Matsuoka Grove
Ravindran Sanuj K
Cubitt Andrew
Falberg Kathryn E
Blackburn Kelly
Ashlock Melissa A
McKew John C
Chrzanowski Holly D
Graham Marcy
Ramsdell Fred
Polaris Venture Partners Entrepreneurs' Fund V LP
Polaris Venture Partners V LP
Polaris Venture Partners Special Founders' Fund V LP
Polaris Venture Management Co V LLC
Polaris Venture Partners Founders' Fund V LP
Park John Joseph
CHP II LP
Hull Brandon H
CHP II Management LLC
Alta Partners Management VIII LLC
Nohra Guy P
Champsi Farah
Alta Partners VIII LP
Janney Daniel
Sofinnova Management IX LLC
Sofinnova Venture Partners IX LP
Powell Michael
Mehra Anand
Healy James
Deerfield Special Situations Fund LP
Deerfield Management Company LP
Deerfield Capital LP
Deerfield Mgmt III LP
Deerfield Private Design Fund III LP
Flynn James E
Vitullo Nicole
Treu Jesse I
Schoemaker Kathleen K
Domain Partners VIII LP
Dovey Brian H
Halak Brian K
DP VIII Associates LP
Weiner David M
Chereau Frederic
Kamdar Kim P
Domain Associates
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
aTYR Pharma Inc ATYR
Common Stock
2026-02-04 Sell 1,558 $0.98 1,527
aTYR Pharma Inc ATYR
Common Stock
2026-02-04 Sell 1,118 $0.98 1,096
aTYR Pharma Inc ATYR
Common Stock
2026-02-04 Sell 3,745 $0.98 3,670
aTYR Pharma Inc ATYR
Restricted Stock Unit · derivative
2026-02-03 Option exercise 3,750 $0.00
aTYR Pharma Inc ATYR
Common Stock
2026-02-03 Option exercise 3,750
aTYR Pharma Inc ATYR
Restricted Stock Unit · derivative
2026-02-03 Option exercise 2,687 $0.00
aTYR Pharma Inc ATYR
Common Stock
2026-02-03 Option exercise 2,687
aTYR Pharma Inc ATYR
Common Stock
2026-02-03 Option exercise 10,375
aTYR Pharma Inc ATYR
Restricted Stock Unit · derivative
2026-02-03 Option exercise 10,375 $0.00
aTYR Pharma Inc ATYR
Employee Stock Options (right to buy) · derivative
2026-01-09 Grant 412,500 $0.00
aTYR Pharma Inc ATYR
Employee Stock Option (right to buy) · derivative
2026-01-09 Grant 1,500,000 $0.00
aTYR Pharma Inc ATYR
Employee Stock Option (right to buy) · derivative
2026-01-09 Grant 412,500 $0.00
aTYR Pharma Inc ATYR
Common Stock
2025-10-09 Buy 317,999 $0.94 298,919
aTYR Pharma Inc ATYR
Common Stock
2025-10-08 Buy 682,001 $0.90 613,801
aTYR Pharma Inc ATYR
Stock Option (right to buy) · derivative
2025-05-01 Grant 50,000 $0.00
aTYR Pharma Inc ATYR
Stock Option (right to buy) · derivative
2025-05-01 Grant 50,000 $0.00
aTYR Pharma Inc ATYR
Stock Option (right to buy) · derivative
2025-05-01 Grant 50,000 $0.00
aTYR Pharma Inc ATYR
Stock Option (right to buy) · derivative
2025-05-01 Grant 50,000 $0.00
aTYR Pharma Inc ATYR
Stock Option (right to buy) · derivative
2025-05-01 Grant 50,000 $0.00
aTYR Pharma Inc ATYR
Stock Option (right to buy) · derivative
2025-05-01 Grant 50,000 $0.00
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com